- Supported exchanges /
- TWO /
- 6620.TWO
Handa Pharmaceuticals Inc. (6620 TWO) stock market data APIs
Handa Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States and China. The company provides Quetiapine XR for the treatment of Schizophrenia; and Dexlansoprazole DR capsules. It also develops ONCORE, a proprietary drug delivery technology that was developed to improve the patient compliance and safety of the tyrosine kinase inhibitor of oncology drugs; 505(b)(2)NDA, a therapeutic product; Tascenso ODT for the treatment of multiple sclerosis; and HND-033 and HND-027, an oncology products. In addition, the company develops HND-004, a diabetic drug; HND-032 for smoking cessation; and HND-026, a GI drug. Handa Pharmaceuticals, Inc. was founded in 2014 and is headquartered in Tainan City, Taiwan.
Handa Pharmaceuticals Inc. Financial Data Overview
| 63.5 | |
| 64.6 | |
| - | |
| 65.1 | |
| 63 | |
| 63-204.5793 | |
| 8 921 M | |
| 19.9686 | |
| 140 M | |
| 973 M | |
| 0.0154 | |
| 1.305 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Handa Pharmaceuticals Inc. Fundamental Data is available in our Financial Data APIs
- Net Revenue 973 M
- EBITDA 529 M
- Earnings Per Share 3.18
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Handa Pharmaceuticals Inc. Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get Handa Pharmaceuticals Inc. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
